NEUTRONENEINFANGTHERAPIESYSTEM

Patent europeic · EP3957362 · En vigur

Inscripziun en il register

Numer da publicaziun
EP3957362
Numer da la dumonda
EP20791113
Gener
Patent europeic cun effect per la Svizra ed il Liechtenstein
Status
En vigur
Scrittira da patent
Concedì
Annunzià
17-03-2020
Publitgà
23-02-2022
Concedì
20-05-2026
La protecziun finescha il pli tard
16-03-2040
Proxima taxa annuala scadenta
31-03-2027
Classas IPC
A61N 5/10 (2006.01)
G21K 1/02 (2006.01)
G21K 5/02 (2006.01)
G21K 1/10 (2006.01)
Prioritad
CN 201910308039 17.04.2019
CN 201910308298 17.04.2019
CN 201910623203 11.07.2019
Dumonda PCT
PCT/CN2020/079653 17.03.2020
Publicaziun PCT
WO2020/211581 22.10.2020
Lingua da l’annunzia
chinais
Funtauna
Swissreg

Istorgia

Quai che l’Institut federal da la proprietad intellectuala ha publitgà davart quest titel, il pli nov l’emprim.

  1. 20-05-2026

    Concedì

    Specification status
    Non-published patent application → Granted patent
    Status of protective title
    Initiated → Active

    Published in Swissreg on 20.05.2026

Partidas

Possessur

Neuboron Therapy System Ltd.

No. 2036 Wengjiao West Road, Haicang District, Xiamen, Fujian 361026, CN

Inventur

CHEN, Wei-Lin

Nanjing, Jiangsu 211112, CN

JIANG, Tao

Nanjing, Jiangsu 211112, CN

YAN, Fa-Zhi

Nanjing, Jiangsu 211112, CN

Il register numna mintga partida cun num ed adressa. In possessur u in represchentant vegn collià cun in’organisaziun, sch’exact ina unitad giuridica dal register da commerzi porta ses num; la via d’ina partida betg enconuschida uschia na vegn betg mussada qua.